P1.01. A Phase IB Trial Of Nivolumab For Immunoprevention Of Bronchial Dysplasia Progression In High-risk Current And Former Smokers - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Hui Yu
Meta Tag
Speaker Hui Yu
Topic Risk Factors, Risk Reduction & Tobacco Control
Bronchial Dysplasia
High-risk Smokers
Lung Squamous Cell Carcinoma
Immune Checkpoint Inhibitors
Histologic Score
Immune Microenvironment
Mutational Load
Ongoing Study
Powered By